Goal and Learning Outcomes

The goal of this continuing education program is to connect Florence Nightingale’s legacy with nurses’ knowledge and capacities to influence local-to-global health, including being a healthy nurse, and working toward achieving the 17 United Nations Sustainable Development Goals and Agenda for Sustainable Development from (2015 to 2030). This will strengthen nurses’ leadership and global impact in practice, education, research, and healthcare policy. After studying the information presented here, you will be able to:
  • Discuss the relevance of healthy nurses for personal and planetary health
  • Link Nightingale’s life, work, and insights with her legacy for 21st century nursing and healthcare
  • Describe connections between key global health issues — including the UN’s 17 SDGs — and the challenges nurses face today
  • Discuss how nurse coaching contributes to achieving these SDGs

Course Authors

Accreditation Information


In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791



Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses


Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.



None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.